시장보고서
상품코드
1272629

세계의 더말 필러 시장 예측(-2030년)

Global Dermal Fillers Market Forecast to 2030

발행일: | 리서치사: Market Research Future | 페이지 정보: 영문 78 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 더말 필러 시장은 미용 성형 수술의 인기 증가가 예측 기간 동안 시장 성장의 주요 촉진제가 될 것으로 예상됩니다. 평가 기간 동안 남성과 여성 모두 얼굴 수술의 인기가 높아지면서 시장 성장에 큰 영향을 미칠 것으로 예상됩니다.

이 보고서는 세계 더말 필러(Dermal Fillers) 시장을 조사 분석하여 시장 역학, 지역 및 부문 분석, 기업 프로파일 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 서론

제3장 조사 방법

제4장 시장 역학

  • 개요
  • 성장 촉진요인
    • 세계적으로 높아지는 페이셜 에스테틱 수요
    • 성형 외과의가 실시하는 미용 시술 건수 증가
    • 미용성형 수술을 대신하는 비용 효율이 높은 대체 수단
  • 성장 억제요인
    • 더말 필러에 관련된 부작용
    • 더말 필러 블랙 마켓과 미등록 의사의 영향
  • 기회
    • 임상시험 증가
    • 저침습수술에 대한 수요 증가

제5장 시장 요인 분석

  • Porter의 Five Forces 분석
  • 밸류체인 분석
    • 연구개발
    • 미용 상품 제조 공정
    • 마케팅과 유통

제6장 더말 필러 시장 : 유형별

  • 개요
  • 히알루론산
  • 폴리머 및 입자
  • 칼슘 하이드록시 어퍼타이트
  • 콜라겐

제7장 더말 필러 시장 : 브랜드별

  • 개요
  • JUVEDERM 39
  • RADIESSE 39
  • RESTYLANE 40

제8장 더말 필러 시장 : 용도별

  • 개요
  • 페이스라인 교정 트리트먼트
  • 페이스 리프트
  • 립 트리트먼트

제9장 세계의 더말 필러 시장 : 지역별

  • 개요
  • 미국
    • 북미
    • 라틴아메리카
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 한국
    • 인도
    • 싱가포르
    • 말레이시아
    • 인도네시아
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동
    • 아프리카

제10장 경쟁 구도 : 세계의 더말 필러 시장

  • 개요
  • 경쟁 분석
  • 경쟁 대시보드
  • 경쟁 벤치마킹
  • 세계 더말 필러 시장의 주요 성장 전략
  • 개발 건수 기준 주요 기업
  • 주요 발전과 성장 전략
    • 인수
    • 제품 승인과 발매
    • 확장
  • 주요 기업의 재무 매트릭스와 시장 비율
    • 판매
    • 연구개발비

제11장 기업 개요

  • GALDERMA LABORATORIES, L.P.
  • ALLERGAN
  • MERZ PHARMA
  • DR. KORMAN LABORATORIES
  • SINCLAIR PHARMA
  • TEOXANE LABORATORIES
  • SUNEVA MEDICAL
  • SCIVISION BIOTECH INC.
  • MEDYTOX

제12장 부록

LSH 23.05.24

Market Overview

According to MRFR's study of the dermal filler market, the rising popularity of cosmetic surgery is anticipated to be a key driver of market growth throughout the forecast period. It is projected that during the assessment period, the rising popularity of facial operations among both men and women will have a significant impact on market growth. In addition, main players' ongoing technical advancement in dermal fillers is anticipated to be advantageous for the sector in the coming years. Over the time of the investigation, the market has benefited significantly from the rising demand for minimally invasive procedures. To match the growing demand, manufacturers are releasing a variety of cutting-edge products, which is expected to spur growth in the ensuing period.

Segment Overview

The Global Dermal Fillers market consists of three main types of segment insights: Type, Application, and Brand.

Hyaluronic acid is anticipated to experience the highest CAGR of any form of dermal filler throughout the projection period.

The lip treatment and facial line correcting treatment segments are estimated to generate strong market worth during the forecast timeframe in the application section of a global dermal fillers market.

The Americas is anticipated to gain the biggest market share throughout the analysis period, according to MRFR's report on the dermal fillers market.

Regional Analysis

The Americas is anticipated to gain the biggest market share throughout the analysis period, according to MRFR's report on the dermal fillers market. The rising necessity for minimally invasive facial surgeries and the rising demand for cosmetic items both contribute to the regional market's expansion. Also, the expanding number of clinical studies for cutting-edge skin beauty products is projected to further stimulate the local market. The US is expected to contribute significantly to the growth of the regional market among all the countries in the region.

Over the projected period, Europe is anticipated to hold the second-largest market share for dermal fillers. The region's market is expected to be significantly influenced by the rising popularity of minimally-invasive methods of face enhancement in the ensuing years. Another significant factor that is anticipated to boost the sales of cosmetic procedures in the region is the rising number of product licenses and product access throughout the region.

Major Players

Suneva Medical (US), Sinclair Pharma (UK), Medytox (South Korea), Merz Pharma (Germany), SciVision Biotech Inc. (Taiwan), Galderma Laboratories, LP (Switzerland), Allergan (Ireland), Dr. Korman Laboratories (Israel), and Teoxane Laboratories (Switzerland) are a few of the companies that work for the Global Dermal Fillers.

COVID 19 Impacts

The research by MRFR predicts that the coronavirus outbreak will have a detrimental effect on the world market. In 2018, the market is probably going to have a 40% decline from 2019. The lockdown that was imposed on a global front resulted in the closure of numerous cosmetic facilities and clinics. The number of cosmetic procedures is declining due to the rising incidence of coronavirus, which has a detrimental effect on the size of the dermal fillers industry. Dermal fillers are frequently utilised in procedures that are minimally invasive as a facial firmness and wrinkle-reduction anti-aging treatment. Several types of products are used with dermal fillers to improve the look of scars, eliminate wrinkles, soften face creases, and enhance shallow contours. Dermal fillers are becoming more widely accepted among people of all ages as awareness of the advantages they have over surgical procedures grows. The global market for dermal fillers is being impacted by the corona virus pandemic. the COVID-19 corona virus illness outbreak in 2018. As of right today, it has killed 281,736 individuals and impacted more over 4 million people worldwide.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW 13
    • 1.1.1 MARKET SYPNOSIS 14

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 15
  • 2.2 RESEARCH OBJECTIVE 15
  • 2.3 LIST OF ASSUMPTIONS 15

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW 17
  • 3.2 DATA MINING 17
  • 3.3 SECONDARY RESEARCH 18
  • 3.4 PRIMARY RESEARCH 19
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20
  • 3.5 FORECASTING TECHNIQUES 20
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
    • 3.6.1 BOTTOM-UP APPROACH 22
    • 3.6.2 TOP-DOWN APPROACH 23
  • 3.7 DATA TRIANGULATION 24
  • 3.8 VALIDATION 24

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 25
  • 4.2 DRIVERS 26
    • 4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS GLOBALLY 26
    • 4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS 26
    • 4.2.3 COST-EFFECTIVE ALTERNATIVE TO COSMETIC SURGERIES 26
    • 4.2.4 RESTRAINTS 28
    • 4.2.5 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS 28
    • 4.2.6 BLACK MARKET OF DERMAL FILLERS AND EFFECTS OF UNREGISTERED PRACTITIONERS 29
  • 4.3 OPPORTUNITIES 30
    • 4.3.1 INCREASING NUMBER OF CLINICAL TRIAL STUDIES 30
    • 4.3.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 30

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTERS FIVE FORCES 31
    • 5.1.1 THREAT OF NEW ENTRANTS 32
    • 5.1.2 BARGAINING POWER OF SUPPLIERS 32
    • 5.1.3 THREAT OF SUBSTITUTES 32
    • 5.1.4 BARGAINING POWER OF BUYERS 32
    • 5.1.5 INTENSITY OF RIVALRY 32
  • 5.2 VALUE CHAIN ANALYSIS 33
    • 5.2.1 RESEARCH AND DEVELOPMENT 34
    • 5.2.2 MANUFACTURING PROCESS OF AESTHETIC PRODUCTS 34
    • 5.2.3 MARKETING AND DISTRIBUTION 34

6 DERMAL FILLERS MARKET, BY TYPE

  • 6.1 OVERVIEW 35
  • 6.2 HYALURONIC ACID 36
  • 6.3 POLYMERS & PARTICLES 36
  • 6.4 CALCIUM HYDROXYLAPATITE 37
  • 6.5 COLLAGEN 37

7 DERMAL FILLERS MARKET, BY BRAND

  • 7.1 OVERVIEW 38
  • 7.2 JUVEDERM 39
  • 7.3 RADIESSE 39
  • 7.4 RESTYLANE 40

8 DERMAL FILLERS MARKET, BY APPLICATION

  • 8.1 OVERVIEW 41
  • 8.2 FACIAL LINE CORRECTION TREATMENT 42
  • 8.3 FACE-LIFT 42
  • 8.4 LIP TREATMENTS 43

9 GLOBAL DERMAL FILLERS MARKET, BY REGION

  • 9.1 OVERVIEW 44
  • 9.2 AMERICAS 46

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.2.1 NORTH AMERICA 48

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

      • 9.2.1.1 US 49

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

      • 9.2.1.2 CANADA 50

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.2.2 LATIN AMERICA 51

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

  • 9.3 EUROPE 53

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.1 GERMANY 55

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.2 UK 56

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.3 FRANCE 57

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.4 ITALY 58

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.5 SPAIN 59

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.6 REST OF EUROPE 60

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

  • 9.4 ASIA-PACIFIC 61

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.1 JAPAN 63

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.2 CHINA 64

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.3 SOUTH KOREA 65

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.4 INDIA 66

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.5 SINGAPORE 67

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.6 MALAYSIA 68

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.7 INDONESIA 69

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.8 REST OF ASIA-PACIFIC 70

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

  • 9.5 MIDDLE EAST AND AFRICA 71

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.5.1 MIDDLE EAST 73

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.5.2 AFRICA 74

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

10 COMPETITIVE LANDSCAPE: GLOBAL DERMAL FILLERS MARKET

  • 10.1 OVERVIEW 76
  • 10.2 COMPETITIVE ANALYSIS 76
  • 10.3 COMPETITOR DASHBOARD 77
  • 10.4 COMPETITIVE BENCHMARKING 78
  • 10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL DERMAL FILLERS MARKET 79
  • 10.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 79
  • 10.7 KEY DEVELOPMENTS AND GROWTH STRATEGIES 80
    • 10.7.1 ACQUISITION 80
    • 10.7.2 PRODUCT APPROVAL AND LAUNCH 80
    • 10.7.3 EXPANSION 81
  • 10.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 82
    • 10.8.1 SALES 82
    • 10.8.2 R&D EXPENDITURE 82

11 COMPANY PROFILES

  • 11.1 GALDERMA LABORATORIES, L.P. 83
    • 11.1.1 COMPANY OVERVIEW 83
    • 11.1.2 FINANCIAL OVERVIEW 83
    • 11.1.3 PRODUCTS/SERVICES OFFERED 83
    • 11.1.4 KEY DEVELOPMENTS 83
    • 11.1.5 SWOT ANALYSIS 84
    • 11.1.6 KEY STRATEGIES 84
  • 11.2 ALLERGAN 85
    • 11.2.1 COMPANY OVERVIEW 85
    • 11.2.2 FINANCIAL OVERVIEW 85
    • 11.2.3 PRODUCTS/SERVICES OFFERED 86
    • 11.2.4 ALLERGAN: KEY DEVELOPMENTS 86
    • 11.2.5 SWOT ANALYSIS 87
    • 11.2.6 KEY STRATEGIES 87
  • 11.3 MERZ PHARMA 88
    • 11.3.1 COMPANY OVERVIEW 88
    • 11.3.2 FINANCIAL OVERVIEW 88
    • 11.3.3 PRODUCTS/SERVICES OFFERED 89
    • 11.3.4 KEY DEVELOPMENTS 89
    • 11.3.5 SWOT ANALYSIS 90
    • 11.3.6 KEY STRATEGIES 90
  • 11.4 DR. KORMAN LABORATORIES 91
    • 11.4.1 COMPANY OVERVIEW 91
    • 11.4.2 FINANCIAL OVERVIEW 91
    • 11.4.3 PRODUCTS/SERVICES OFFERED 91
    • 11.4.4 KEY DEVELOPMENTS 91
    • 11.4.5 SWOT ANALYSIS 92
    • 11.4.6 KEY STRATEGIES 92
  • 11.5 SINCLAIR PHARMA 93
    • 11.5.1 COMPANY OVERVIEW 93
    • 11.5.2 FINANCIAL OVERVIEW 93
    • 11.5.3 PRODUCTS/SERVICES OFFERED 94
    • 11.5.4 KEY DEVELOPMENTS 94
    • 11.5.5 SWOT ANALYSIS 94
    • 11.5.6 KEY STRATEGIES 95
  • 11.6 TEOXANE LABORATORIES 96
    • 11.6.1 COMPANY OVERVIEW 96
    • 11.6.2 FINANCIAL OVERVIEW 96
    • 11.6.3 PRODUCTS/SERVICES OFFERED 96
    • 11.6.4 KEY DEVELOPMENTS 97
    • 11.6.5 SWOT ANALYSIS 97
    • 11.6.6 KEY STRATEGIES 97
  • 11.7 SUNEVA MEDICAL 98
    • 11.7.1 COMPANY OVERVIEW 98
    • 11.7.2 FINANCIAL OVERVIEW 98
    • 11.7.3 PRODUCTS/SERVICES OFFERED 98
    • 11.7.4 KEY DEVELOPMENTS 98
    • 11.7.5 SWOT ANALYSIS 99
    • 11.7.6 KEY STRATEGIES 99
  • 11.8 SCIVISION BIOTECH INC. 100
    • 11.8.1 COMPANY OVERVIEW 100
    • 11.8.2 FINANCIAL OVERVIEW 100
    • 11.8.3 PRODUCTS/SERVICES OFFERED 100
    • 11.8.4 KEY DEVELOPMENTS 100
    • 11.8.5 SWOT ANALYSIS 101
    • 11.8.6 KEY STRATEGIES 101
  • 11.9 MEDYTOX 102
    • 11.9.1 COMPANY OVERVIEW 102
    • 11.9.2 FINANCIAL OVERVIEW 102
    • 11.9.3 PRODUCTS/SERVICES OFFERED 102
    • 11.9.4 KEY DEVELOPMENTS 102
    • 11.9.5 SWOT ANALYSIS 103
    • 11.9.6 KEY STRATEGIES 103

12 APPENDIX

  • 12.1 REFERENCES 104
  • 12.2 RELATED REPORTS 104
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제